Score Overview
Explore the 2021 public Archive ranking →
Where Quest Diagnostics Incorporated has ranked, year by year
Showing 5 years ranking history by HDB Score.
Reached the top 50 on HDB Score in 2 years, the longest run being 2 in a row — but not in 2021.
- DGX
2002: 28.0% · 2021: 25.3% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-28 | $ 237.62 | — |
1 Year2025-09-26 | $ 185.73 | 27.94% |
5 Years2021-09-28 | $ 131.89 | 80.16% |
10 Years2016-09-28 | $ 69.37 | 242.54% |
20 Years2006-09-28 | $ 44.40 | 435.22% |
All Time1996-12-17 | $ 2.46 | 96x |
| Period | Last Price2026-09-28 | 1 Year2025-09-26 | 5 Years2021-09-28 | 10 Years2016-09-28 | 20 Years2006-09-28 | All Time1996-12-17 |
|---|---|---|---|---|---|---|
| Price | $ 237.62 | $ 185.73 | $ 131.89 | $ 69.37 | $ 44.40 | $ 2.46 |
| Return | — | 27.94% | 80.16% | 242.54% | 435.22% | 96x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 11.56B | $ 1.06B | $ 626M |
| 2025 | $ 11.03B | $ 992M | $ 420M |
| 2024 | $ 9.87B | $ 871M | $ 549M |
| 2023 | $ 9.25B | $ 854M | $ 686M |
| 2022 | $ 9.88B | $ 946M | $ 315M |
| 2021 | $ 10.78B | $ 1.99B | $ 872M |
| 2020 | $ 9.43B | $ 1.43B | $ 1.15B |
| 2019 | $ 7.72B | $ 858M | $ 1.19B |
| 2018 | $ 7.53B | $ 736M | $ 135M |
| 2017 | $ 7.70B | $ 772M | $ 137M |
| 2016 | $ 7.51B | $ 645M | $ 359M |
| 2015 | $ 7.49B | $ 709M | $ 133M |
| 2014 | $ 7.43B | $ 556M | $ 192M |
| 2013 | $ 7.14B | $ 849M | $ 187M |
| 2012 | $ 7.38B | $ 555M | $ 295M |
| 2011 | $ 7.51B | $ 470M | $ 164M |
| 2010 | $ 7.36B | $ 720M | $ 449M |
| 2009 | $ 7.45B | $ 729M | $ 534M |
| 2008 | $ 7.24B | $ 581M | $ 253M |
| 2007 | $ 6.70B | $ 339M | $ 167M |
| 2006 | $ 6.26B | $ 586M | $ 149M |
| 2005 | $ 5.50B | $ 546M | $ 92M |
| 2004 | $ 5.12B | $ 499M | $ 73M |
| 2003 | $ 4.73B | $ 436M | $ 154M |
| 2002 | $ 4.10B | $ 322M | $ 96M |
| 2001 | $ 3.62B | $ 162M | $ 122M |
| 2000 | $ 3.42B | $ 102M | $ 171M |
| 1999 | $ 2.20B | -$ 3M | $ 27M |
| 1998 | $ 1.45B | $ 26M | $ 202M |
| 1997 | $ 1.52B | -$ 22M | $ 161M |
| IPO1996 | $ 1.61B | -$ 625M | $ 41M |
Quest Diagnostics Incorporated fundamental performance
Between 2005 and 2025, revenue grew from $ 5.50B to $ 11.03B and net income grew from $ 546M to $ 992M. Revenue increased in 14 of those 20 years; net income in 12.
Across Quest Diagnostics Incorporated's full reported history, from 1996 to 2025, revenue grew from $ 1.61B to $ 11.03B and net income went from -$ 625M to $ 992M. Revenue increased in 73% of the years measured; net income in 70%.
Quest Diagnostics Incorporated currently holds a 20-year HDB Score of 5.7 out of 10. How the HDB Score is calculated.
Membership
Continue DGX’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,816 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
